92227 ⎘
Methods and compositions for treatment of muscle wasting, muscle weakness, and/or cachexia
#2N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamides and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamides and their therapeutic use
#3Trans-metallated MOF catalyst
#4Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
#5Heterogeneous catalytic transesterification of ester compounds with groups reactive under transesterification conditions
#6KCNQ potassium channel agonist, and preparation method therefor and use thereof
#7Compounds for treating diabetes
#8Substituted hydroxystilbenes and their therapeutic applications
#9Method of inhibiting apolipoprotein-E expression while increasing expression of at least one of LDL-receptor protein or AbcA1 protein comprising administering a small compound
#10SYNTHESIS OF A SUBSTITUTED INDENE DERIVATIVE
#11Catalyst for fixed bed aniline rectification residue recycling and preparation method
#12Compositions and methods for reduction of ketones, aldehydes and iminiums, and products produced thereby
#13Method of manufacturing BHCD and derivatives thereof
#14Metal organic frameworks as catalysts and hydrocarbon oxidation methods thereof
#15Compound, electrophotographic photoreceptor, and process cartridge
#16Trisamide compounds and compositions comprising the same
#17SHIP1 MODULATORS AND METHODS RELATED THERETO
#18Compounds having a difluorocyclohexane ring, liquid crystal compositions and liquid crystal display devices
#19Monomer, polymer, resist composition, and patterning process
#20Metal oxide catalyzed radiofluorination
#21N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamides and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamides and their therapeutic use
#22COMPOUND HAVING A DIFLUOROCYCLOHEXANE RING, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE
#23LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE INCLUDING THE SAME
#24Synthesis of a substituted indene derivative
#25Chiral diamine compounds for the preparation of chiral alcohols and chiral amines
#26Process and system for making cyclohexanone
#27METHOD FOR PRODUCING POLYMERIZABLE COMPOUND
#28Benzenesulfonamido and related compounds for use as agonists of RORγ and the treatment of disease
#29Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
#30CRYSTALLINE FORM OF y-AMINOBUTYRIC ACID ANALOG
#31EP4 agonists as therapeutic compounds
#32RESIST COMPOSITION, METHOD FOR FORMING RESIST PATTERN, POLYPHENOLIC COMPOUND FOR USE IN THE COMPOSITION, AND ALCOHOLIC COMPOUND THAT CAN BE DERIVED THEREFROM
#33Compound and liquid-crystal composition employing the same
#34COMPOUND AND LIQUID CRYSTAL COMPOSITION EMPLOYING THE SAME
#35Polymerizable compound, polymer, polymerizable composition, and film
#36Methods of preparing α,β-unsaturated or α-halo ketones and aldehydes
#37Method for synthezising cyclohexenones for use in the perfume industry and compounds obtained thereby
#38High heat monomers and methods of use thereof
#39Imidamide sphingosine kinase inhibitors
#40Process for Preparing N-(4-Cyclohexyl-3-trifluoromethyl-benzyloxy)-acetimidic Acid Ethyl Ester
#41Photosensitive composition and compound
#42Thickening stabilizer and thickening stabilization composition using same
#43Automated synthesis of small molecules using chiral, non-racemic boronates
#44Production intermediate of polymerizable compound, production method for same, composition, and stabilization method
#45Compositions and methods for quadricyclane modification of biomolecules
#46Organic compounds, light modulating composition and light modulating devices employing the same
#47Conversion of alcohols to carboxylic acids using heterogeneous palladium-based catalysts
#48Electrochemical isomerization of muconic acid
#49Trientine prodrugs, pharmaceutical compositions thereof, and methods of use
#50Tiopronin prodrugs, pharmaceutical compositions thereof, and methods of use
#51Mesoporous and macroporous nickel-based catalyst having a median macropore diameter of greater than 200 nm and its use with regard to hydrogenation
#52Diamine dione polyalkyl amine synthesis
#5325-OH vitamin D derivatives for determining vitamin D metabolites
#54Modulators of sestrin-GATOR2 interaction and uses thereof
#55N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and their use thereof
#56LOW CALCEMIC, HIGHLY ANTIPROLIFERATIVE, ANALOGS OF CALCITRIOL
#57Compositions relating to vitamin D
#58Immunoregulatory agents
#59NOVEL RUTHENIUM COMPLEXES AND THEIR USES IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND DERIVATIVES THEREOF
#60Composite metal catalyst composition, and method and apparatus for preparing 1,4-cyclohexanedimethanol using same
#61Fluorene derivative, light-emitting element, light-emitting device, electronic device, and lighting device
#62Liquid crystal compound and liquid crystal composition
#63Liquid crystal composition and liquid crystal display comprising the same
#64Compositions and Methods Relating to Ionic Salts of Peptides
#65ANTIBACTERIAL AGENTS
#66Inhibitors of fatty acid amide hydrolase (FAAH) enzyme with improved oral bioavailability and their use as medicaments
#67LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE INCLUDING THE SAME
#68Methods of producing compounds from 5-(halomethyl)furfural
#69KCNQ potassium channel agonists, method of preparation and method of use thereof
#70Guanidine compounds and use thereof
#71Synthesis of acyclic and cyclic amines using iron-catalyzed nitrene group transfer
#72LXR agonists and uses thereof
#73Analogs of fexaramine and methods of making and using
#74Method for producing menthones from isopulegol in the gas phase
#75Ruthenium-phenol catalysts and method of preparing menthone from isopulegol
#76N-arylamidine-substituted trifluoroethyl sulfide derivatives as acaricides and insecticides
#77SYNTHESIS OF ARYL CYCLOHEXANE CARBOXAMIDE DERIVATIVES USEFUL AS SENSATES IN CONSUMER PRODUCTS
#78SYSTEM AND METHOD FOR HYDROGENATING AROMATIC COMPOUND
#79Mononuclear ruthenium complex and organic synthesis reaction using same
#80Crystalline form of chlorogenic acid and preparation method thereof
#81Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain
#82Alkoxy compounds for disease treatment
#83TERPENE AND TERPENOID DERIVATIVES CONTAINING VINYL GROUPS FOR THE PREPARATION OF POLYMERS
#84Ruthenium-based triazole carbene complexes
#85Tetracycline compounds
#86COMPOUNDS FOR THE TREATMENT OF SEIZURES AND OTHER CENTRAL NERVOUS SYSTEM DISORDERS AND CONDITIONS
#87RADIATION-SENSITIVE RESIN COMPOSITION, RESIST PATTERN-FORMING METHOD, ACID GENERATOR AND COMPOUND
#88Liquid-crystalline medium
#89Rapid-curing, migration-free composition based on organic polymers containing silane groups
#90Opsin-Binding Ligands, Compositions and Methods for Use
#91Method of chromatographic separation
#92Process for preparing aryl ketone
#93Neutralization of acidic catalysts in the production of phenol
#94Synthesis and biological activity of 2-methylene analogs of calcitriol and related compounds
#95Liquid crystal composition and liquid crystal display including the same
#96BIS(PHOSPHINE)-CARBODICARBENE CATALYST COMPLEXES AND METHODS OF USING THE SAME
#97N-alkoxyamide conjugates as imaging agents
#98Allenamide as an orthogonal handle for selective modification of cysteine in peptides and proteins
#99Compound, and flavor and/or fragrance composition containing said compound
#100Method for manufacturing α-bromoacetophenone compound
#101Method and system for forming plug and play metal catalysts
#102Bridged phthalocyanine- and napththalocyanine-metal complex catalysts and methods of using and purifying the same
#103Aryl and heteroaryl ether compounds as ROR gamma modulators
#104Process for preparing 1,1-disubstituted ethylene monomers
#105Dicarboxylic acid compound
#106Method for producing polymerizable compound
#107Monomer, polymer, positive resist composition, and patterning process
#108Liquid crystal composition and liquid crystal display including the same
#109Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions
#110Derivatives of 1-(4-methylcyclohexyl)-ethanols
#111ADO-resistant cysteamine analogs and uses thereof
#112FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE
#113FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE
#114Cyclohexylbenzene composition
#115Co-crystals of tramadol and coxibis
#116LIQUID CRYSTAL COMPOUND HAVING TETRAFLUOROFLUORENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE
#117Nitro-containing bisoxime ester photoinitiator and preparation method and use thereof
#118Crystalline solid forms of the acetate salt of (1S,3S,4R)-4-((3aS,4R,5S,7aS)-4-(aminomethyl)-7a-methyl-1-methyleneoctahydro-1H-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexanol
#119Process for Making Cyclohexylbenzene and/or Phenol and/or Cyclohexanone
#120Cannabidinoid derivatives
#121Process for making phenol and/or cyclohexanone
#122Photoresist composition, compound, and production method thereof
#123Epoxy-amine adduct, resin composition, sizing agent, carbon fiber coated with sizing agent, and fiber-reinforced composite material
#124Buprenorphine dimer and its use in treatment of gastrointestinal disorders
#125PHARMACEUTICALLY ACTIVE DIMERS LINKED THROUGH PHENOLIC HYDROXYL GROUPS
#126Amide derivative
#127(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
#128Treprostinil derivatives and compositions and uses thereof
#129Treprostinil derivatives and compositions and uses thereof
#130Liquid crystal compound having 1,1,3,3-tetrafluoroallyloxy group, liquid crystal composition and liquid crystal display device
#131Liquid crystal composition and liquid crystal display including the same
#132iNKT cell modulators and methods of using the same
#133ANTICONVULSANT COMPOUNDS
#134Titanium-silicalite molecular sieve, method for preparing the same and method for preparing cyclohexanone oxime using the molecular sieve
#135Physiological cooling compounds
#136Solid Forms Comprising(-)-O-Desmethylvenlafaxine And Uses Thereof
#137PLANT EXTRACTS AND USE THEREOF
#138Liquid crystal composition and liquid crystal display device comprising the same
#139(Meth)acrylate compound, (meth)acrylic copolymer and photosensitive resin composition containing same
#140Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
#141Acid generator compounds and photoresists comprising same
#142Catalyst, and method for producing oxidation product
#143Photolabile pro-fragrances
#144Single-pot synthesis of dialkyl carbonates using catalyst from natural resource
#145Ethers of bis(hydroxymethyl)cyclohexanes
#146Polymer, monomer, resist composition, and patterning process
#147Liquid crystal compound having tetracycle, liquid crystal composition and liquid crystal display device
#148Borate-based base generator, and base-reactive composition comprising such base generator
#149Organoleptic compounds
#150Substituted (4'-hydroxyphenyl)cyclohexane compounds and uses thereof as selective agonists of the estrogen receptor beta isoform
#151Process for producing 7-dehydrocholesterol and vitamin D3
#15212-epi pleuromutilins
#153(S)-CSA SALT OF S-KETAMINE, (R)-CSA SALT OF S-KETAMINE AND PROCESSES FOR THE PREPARATION OF S-KETAMINE
#154Redox-active metal-organic frameworks for the catalytic oxidation of hydrocarbons
#155Cyclohexanols and their use in perfume compositions
#156Cyclohexanols and their use in perfume compositions
#157Processes for the synthesis of chiral 1-alkanols
#158Compositions comprising a biocidal polyamine
#159LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY INCLUDING THE SAME
#160Iron(II) catalysts containing tridentate PNP ligands, their synthesis, and use thereof
#161Cyclohexyl sulfone RORγ modulators
#162Hydrogenation reaction method
#163Use of cyclohexanol derivatives as antimicrobial active compounds
#164Onium salt, resist composition, and patterning process
#165MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
#166Substituted Urea eIF2alpha Kinase Activators
#167Benzamides and nicotinamides as Syk modulators
#168SUBSTITUTED PHENETHYLAMINES WITH SEROTONINERGIC AND/OR NOREPINEPHRINERGIC ACTIVITY
#169Polymerizable compound, polymerizable composition, film, and half mirror for displaying projection image
#170Acrylamide-based crosslinking monomers, their preparation, and uses thereof
#171Drug target site within GP120 of HIV
#172Allosteric modulators of factor XIa as anticoagulant agents
#173Substituted thioureas as heat shock protein 70 inhibitors
#174Organic salts of glyceride-cyclic carboxylic acid anhydride adducts as corrosion inhibitors
#175PROCESS FOR PREPARING 4-CYCLOHEXYL-2-METHYL-2-BUTANOL
#176GLP-1 receptor stabilizers and modulators
#177ROR gamma (RORγ) modulators
#178Method for hydrogenating aromatic compounds
#179Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
#180Dehydrogenation catalyst, and carbonyl compound and hydrogen production method using said catalyst
#181N-substituted benzamides and methods of use thereof
#182Bis-amide derivative and use thereof
#183Vitamin D analogues of pharmaceutical interest
#184Solvent for producing organic transistor
#185Sulfenamides as flame retardants
#186Process for preparing 3-aminomethyl-3,5,5-trimethylcyclohexylamine
#187Liquid crystal compound having cyclohexene ring, liquid crystal composition and liquid crystal display device
#188Liquid crystal composition and liquid crystal display device
#189Cross-coupling of unactivated secondary boronic acids
#190Gamma amino acid building blocks
#191Asymmetric catalytic decarboxylative alkyl alkylation using low catalyst concentrations and a robust precatalyst
#192Fuel markers and methods of producing and using same
#193Fuel markers and methods of producing and using same
#194PRODUCTION OF RENEWABLE FINE CHEMICALS AND LIQUID FUELS
#195HETEROCYCLIC SULFONAMIDES, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF
#196Process for the preparation of -iodoamides
#197Process for total synthesis of venlafaxine
#198PROCESS FOR HYDROGENATING KETONES IN THE PRESENCE OF RU(II) CATALYSTS
#199THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USE
#200Compounds with (1E, 6E)-1,7-Bis-(3,4-dimethoxyphenyl)-4-4-distributed-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof
#201Process for preparing cis-alkoxy-substituted spirocyclic phenylacetylamino acid esters and cis-alkoxy-substituted spirocyclic 1H-pyrrolidine-2,4-dione derivatives
#202Catalytic hydrogenation for the preparation of amines from amide acetals, ketene N, O-acetals or ester imides
#203Process for making phenol and/or cyclohexanone
#204Liquid crystal composition and liquid crystal display including the same
#2051,4-cyclohexylamine derivatives and processes for the preparation thereof
#206Inhibitors of human immunodeficiency virus replication
#207Process for producing dihydro-2H-pyran derivatives
#208Process for making phenol and/or cyclohexanone
#209Method of producing optically active compound
#210Liquid crystal compound having vinylene group, liquid crystal composition and liquid crystal display device
#211SYNTHETIC INTERMEDIATE OF MAXACALCITOL, PREPARATION METHOD THEREFOR AND USE THEREOF
#212Compounds useful in the treatment of neoplastic diseases
#213Alkyl aromatic hydroalkylation for the production of plasticizers
#214Alkylating process
#215Liquid crystal compound having a 3,6-dihydro-2H-pyran ring, negative dielectric anisotropy, liquid crystal composition and liquid crystal display device
#216METHOD FOR PRODUCING BIS (AMINOMETHYL) CYCLOHEXANE
#217Catalytic transesterification of ester compounds with groups reactive under transesterification conditions
#218PROCESSES FOR MAKING CYCLOHEXANE COMPOUNDS
#219DIRECT B-ARYLATION OF CARBONYL COMPOUNDS
#220PROCESSES FOR MAKING CYCLOHEXANE COMPOUNDS
#221USE OF CERTAIN ORGANIC MATERIALS, CONTAINING ALKALI OR ALKALINE-EARTH METALS, FOR IMPLEMENTING ORGANIC CHEMICAL REACTIONS
#222Thioether derivatives as precursors for a controlled release of active molecules
#223Nematic liquid crystal composition and liquid crystal display element including same
#224Gold loaded TiO2 nanotube-multiwalled carbon nanotube composites as active photocatalysts for cyclohexane oxidation
#225Composition that includes cyclohexyl-substituted tertiary alkanols
#226Liquid crystal composition containing nitrogen-containing cyclic compound and liquid crystal display device
#227LIQUID-CRYSTALLINE MEDIUM
#228Herbicidally active (alkynyl-phenyl)-substituted cyclic dione compounds and derivatives thereof
#229Isomerization method for bis (aminomethyl) cyclohexane
#230CATALYST USED FOR RESOURCE UTILIZATION OF A FIXED BED ANILINE DISTILLATION RESIDUE AND METHOD FOR PREPARING SAID CATALYST
#231Liquid crystal compound having tetrafluoro cyclohexadiene structure showing negative anisotropy, liquid crystal composition, and liquid crystal display device
#232Methods and compositions for selective and targeted cancer therapy
#233Metalloprotease inhibitors, methods for producing same, and therapeutics uses thereof
#234IDO inhibitors
#235NEW PROCESS
#236Compounds having negative optical dispersion, negative optical dispersion composition comprising the compounds, and optically anisotropic body comprising the composition
#237Use of polymers as heterogeneous hydrogen donors for hydrogenation reactions
#238Hydrogenation catalyst, its method of preparation and use
#23925-OH vitamin D derivatives for determining vitamin D metabolites
#240Cyclic olefin compound having photoreactive group and photoreactive polymer
#241Metathesis catalysts and methods thereof
#242T-box riboswitch-binding anti-bacterial compounds
#243Compounds useful as immunomodulators
#244Nematic liquid crystal composition
#245Process for synthesizing highly optically active 1,3-disubstituted allenes
#246N-alkoxyamide conjugates as imaging agents
#247COMPOUNDS WITH ANTIBACTERIAL ACTIVITY
#248Carboxylic acid ester/carbamate compound with polymerizable functional group and fluorine atom group, and manufacturing method therefor
#249Selective olefin metathesis with cyclometalated ruthenium complexes
#250Method and system for forming plug and play metal compound catalysts
#251Monomer, polymer, resist composition, and patterning process
#252Resist composition, method for forming resist pattern, polyphenolic compound for use in the composition, and alcoholic compound that can be derived therefrom
#253PROCESS FOR THE OXIDATION OF CYCLOHEXANE
#254Production and use of dialkylbiphenyl isomer mixtures
#255N-heterocyclic carbene type palladium catalyst and its preparation method as well as applications
#256Salt, acid generator, photoresist composition, and method for producing photoresist pattern
#257Method for the methylation of nitrogen-containing organic compounds
#258Birefringence improving agent, ferroelectric liquid crystal composition and liquid crystal display device using the agent, and compound
#259Organoleptic compounds
#260Method of producing optically active β-aminocarbonyl compound
#261Catalyst and manufacturing method thereof and method for manufacturing hydrogenated bisphenol A or derivatives thereof using the same
#262Use of ruthenium complexes for preparing amides, polypeptides and cyclic dipeptides
#263Compound having perfluoroalkyl terminal group and CFO bonding group, liquid crystal composition and liquid crystal display device
#264Compositions and methods for the treatment of mucositis
#265Catalyst and method for hydrogenation of 4,4′-methylenedianiline
#266Sulfide alkyl compounds for HBV treatment
#267Resist composition, method for forming resist pattern, polyphenolic compound for use in the composition, and alcoholic compound that can be derived therefrom
#268N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamides and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamides and their therapeutic use
#269COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS
#270Triesters from alpha-and-beta-hydroxyesters
#271Method and system for forming plug and play oxide catalysts
#272Compound, resin, resist composition and method for producing resist pattern
#273Immunoregulatory agents
#274IDO inhibitors
#275HDAC inhibitors
#276Antioxidant having difluoromethoxy group, liquid crystal composition, and liquid crystal display device
#2771,3-diaminocyclopentane carboxamide derivatives
#278Bicyclic aryl sphingosine 1-phosphate analogs
#279Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
#280Process for concentrating a mixture containing organic hydroperoxide
#281Catalyst components for the polymerization of olefins
#282Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives
#283α-Substituted glycinamide derivative
#284Process for producing phenol and/or cyclohexanone
#285Methods and compounds for treating proliferative disorders and viral infections
#286Process for producing phenol and/or cyclohexanone
#287Alkylamine derivative
#288Condensed-cyclic compound and organic light-emitting diode including the same
#289Modulators of the eIF2alpha pathway
#290Oligomer-amino acid conjugates
#291Liquid crystal composition and liquid crystal display device
#292Resin composition, film, polarizing plate protective film, polarizing plate, liquid crystal display device, and bis type alicyclic cardo phenol compound
#293Sulfonium salt, resist composition and resist pattern forming process
#294LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY COMPRISING THE LIQUID CRYSTAL COMPOSITION
#295Herbicidally active 2-(substituted-phenyl)-cyclopentane-1,3-dione compounds and derivatives thereof
#296Process of producing polycarbonate by copolymerization of carbon dioxide and epoxide using the same as catalyst
#297Method for producing oxime
#298Low-toxicity olefinic ester compositions and methods of using the same
#299Photolabile pro-fragrances
#300Process for producing phenol